Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Kimber

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|December 1, 1979
Reduction of the high dose hook effect in the serum ferritin assayG Casey, Z Rudzki, R J Kimber
British Journal of Haematology|March 1, 1978
Transferrin-bound iron and its effect on erythropoietin as measured by mouse fetal liver cell assayM Rokicinski, Z Rudzki, R J Kimber
The Journal of Laboratory and Clinical Medicine|May 1, 1976
The clinical value of the radioassay of serum folateZ Rudzki, M Nazaruk, R J Kimber
The Medical Journal of Australia|March 23, 1974
Serum folic acid levels and pregnancy in South Australia. A study of the factors associated with low serum folic acid levels with particular reference to racial groups and lactationJ K Cole, R J Kimber, D Kutkaite
Pathology|October 1, 1983
Clinching the diagnosis: 1. Iron deficiency and iron overload: serum ferritin and serum iron in clinical medicineR J Kimber, Z Rudzki, R W Blunden
The Medical Journal of Australia|March 13, 1971
Causes of thrombocytopenia in a hospital population. A six-months survey of 7,750 patientsR G Pembrey, D A Handley, R J Kimber
Australian and New Zealand Journal of Medicine|May 1, 1972
Traumatic haemolysis after heart valve replacement: a comparison of haematological investigationsW Ducrou, P E Harding, R J Kimber, et al.
Australian and New Zealand Journal of Medicine|October 1, 1981
Radiation veno-occlusive liver diseaseR Rowland, A S Pieterse, R J Kimber, et al.
Annals of Clinical Biochemistry|July 1, 1981
Changes in serum ferritin levels after intravenous ironR W Blunden, J V Lloyd, Z Rudzki, et al.
Leukemia Research|January 1, 1988
Bone marrow biopsy during induction chemotherapy for acute myeloid leukaemia identifies only 50% of patients with resistant diseaseM M Roberts, C A Juttner, L B To, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|December 1, 1979
Reduction of the high dose hook effect in the serum ferritin assayG Casey, Z Rudzki, R J Kimber
British Journal of Haematology|March 1, 1978
Transferrin-bound iron and its effect on erythropoietin as measured by mouse fetal liver cell assayM Rokicinski, Z Rudzki, R J Kimber
The Journal of Laboratory and Clinical Medicine|May 1, 1976
The clinical value of the radioassay of serum folateZ Rudzki, M Nazaruk, R J Kimber
The Medical Journal of Australia|March 23, 1974
Serum folic acid levels and pregnancy in South Australia. A study of the factors associated with low serum folic acid levels with particular reference to racial groups and lactationJ K Cole, R J Kimber, D Kutkaite
Pathology|October 1, 1983
Clinching the diagnosis: 1. Iron deficiency and iron overload: serum ferritin and serum iron in clinical medicineR J Kimber, Z Rudzki, R W Blunden
The Medical Journal of Australia|March 13, 1971
Causes of thrombocytopenia in a hospital population. A six-months survey of 7,750 patientsR G Pembrey, D A Handley, R J Kimber
Australian and New Zealand Journal of Medicine|May 1, 1972
Traumatic haemolysis after heart valve replacement: a comparison of haematological investigationsW Ducrou, P E Harding, R J Kimber, et al.
Australian and New Zealand Journal of Medicine|October 1, 1981
Radiation veno-occlusive liver diseaseR Rowland, A S Pieterse, R J Kimber, et al.
Annals of Clinical Biochemistry|July 1, 1981
Changes in serum ferritin levels after intravenous ironR W Blunden, J V Lloyd, Z Rudzki, et al.
Leukemia Research|January 1, 1988
Bone marrow biopsy during induction chemotherapy for acute myeloid leukaemia identifies only 50% of patients with resistant diseaseM M Roberts, C A Juttner, L B To, et al.
Pageof 4